Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Rosalind Advisors, Inc. reported a 9.80% stake in Fennec Pharmaceuticals Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 11, 2026

Rosalind Advisors, Inc. reported a 9.80% stake in Fennec Pharmaceuticals Inc., 2,746,840 shares, as a passive investor on Dec 31, 2025. Filed Feb 11, 2026 (Schedule 13G/A).

Stake
9.80%
Shares
2,746,840
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Rosalind Advisors, Inc.9.80%2,746,840
SALAMON STEVEN A J9.50%2,680,174
Aharon Gil9.50%2,680,174
Rosalind Master Fund L.P.9.30%2,613,508

Source

View original at SEC

Related